Search

Search Constraints

You searched for: Author/Creator Hackett, Samuel

Search Results

1. Immune related adverse events and treatment discontinuation in patients older and younger than 75 years with advanced melanoma receiving nivolumab or pembrolizumab. Issue 2 (March 2022)